AWMDMG
ALBO

Austin W. Marxe & David M. Greenhouse’s Albireo Pharma Inc ALBO Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-52,823
Closed -$4.99M – 139
2013
Q3 		$4.99M Buy
52,823
+15,810
+43% +$2.06M 0.61% 58
2013
Q2 		$4.64M Buy
+37,013
New +$3.85M 0.63% 57

Other funds holding ALBO

William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
FNYS
First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's ALBO Position: Q4 2013 in Review

Austin W. Marxe & David M. Greenhouse sold out of Albireo Pharma Inc (ALBO) in Q4 2013, closing a stake of 52,823 shares — an estimated $4.99M sold.

Austin W. Marxe & David M. Greenhouse first reported a position in ALBO in Q2 2013 and held it in 2 quarters. The position peaked at $4.99M in Q3 2013. 41 funds tracked by Wall St. Rank hold ALBO as of Q4 2013.

  • Austin W. Marxe & David M. Greenhouse reported no remaining Albireo Pharma Inc position as of Q4 2013 after selling out during the quarter.
  • Austin W. Marxe & David M. Greenhouse sold 52,823 Albireo Pharma Inc shares in Q4 2013, an estimated $4.99M.
  • Austin W. Marxe & David M. Greenhouse first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 2 quarters.
  • Austin W. Marxe & David M. Greenhouse's Albireo Pharma Inc position peaked at $4.99M in Q3 2013.
  • 41 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2013.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q4 2013, filed 6 Feb 2014.